Terms: = Germ cell tumor AND CARS, P49589, 833, ENSG00000110619 AND Treatment
85 results:
1. Characterization of the m6A/m1A/m5C/m7G-related regulators on the prognosis and immune microenvironment of glioma by integrated analysis of scRNA-seq and bulk RNA-seq data.
Yang L; Huang Z; Deng Y; Zhang X; Lv Z; Huang H; Sun Q; Liu H; Liang H; He B; Hu F
J Gene Med; 2024 Feb; 26(2):e3666. PubMed ID: 38391150
[TBL] [Abstract] [Full Text] [Related]
2. Efficacy against Lung Cancer Is Augmented by Combining Aberrantly N-Glycosylated T cells with a Chimeric Antigen Receptor Targeting Fragile X Mental Retardation 1 Neighbor.
Toyofuku T; Ishikawa T; Nojima S; Kumanogoh A
J Immunol; 2024 Mar; 212(5):917-927. PubMed ID: 38214607
[TBL] [Abstract] [Full Text] [Related]
3. PSMA PET/MR is a New Imaging Option for Identifying Glioma Recurrence and Predicting Prognosis.
Xiong M; Chen Z; Zhou C; Yang X; Hu W; Jiang Y; Zheng R; Fan W; Mou Y; Lin X
Recent Pat Anticancer Drug Discov; 2024; 19(3):383-395. PubMed ID: 38214322
[TBL] [Abstract] [Full Text] [Related]
4. Marital Status as an Independent Prognostic Factor in Patients with Glioblastoma: A Population-Based Study.
Hu S; Sun C; Chen M; Zhou J
World Neurosurg; 2024 Feb; 182():e559-e569. PubMed ID: 38061540
[TBL] [Abstract] [Full Text] [Related]
5. Combining CSPG4-CAR and CD20-CCR for treatment of metastatic melanoma.
Teppert K; Winter N; Herbel V; Brandes C; Lennartz S; Engert F; Kaiser A; Schaser T; Lock D
Front Immunol; 2023; 14():1178060. PubMed ID: 37901209
[TBL] [Abstract] [Full Text] [Related]
6. Avelumab treatment for patients with metastatic Merkel cell carcinoma can be safely stopped after 1 year and a PET/CT-confirmed complete response.
Zijlker LP; Levy S; Wolters W; van Thienen JV; van Akkooi ACJ; Tesselaar MET
Cancer; 2024 Feb; 130(3):433-438. PubMed ID: 37788133
[TBL] [Abstract] [Full Text] [Related]
7. Biologically Interpretable Deep Learning To Predict Response to Immunotherapy In Advanced Melanoma Using Mutations and Copy Number Variations.
Zhang L; Cao L; Li S; Wang L; Song Y; Huang Y; Xu Z; He J; Wang M; Li K
J Immunother; 2023 Jul-Aug 01; 46(6):221-231. PubMed ID: 37220017
[TBL] [Abstract] [Full Text] [Related]
8. Skin cancer incidence in transgender individuals receiving gender-affirming hormone treatment: a nationwide cohort study in the Netherlands.
Rahmat A; De Nie I; Wiepjes CM; Den Heijer M; Rustemeyer T; De Blok CJM; Dreijerink KMA
Int J Dermatol; 2023 Jul; 62(7):882-887. PubMed ID: 37140088
[TBL] [Abstract] [Full Text] [Related]
9. IL13Rα2-targeted third-generation CAR-T cells with CD28 transmembrane domain mediate the best anti-glioblastoma efficacy.
Gu A; Bai Y; Zhang C; Xu C; An Z; Zhang Y; Zhong SH; Hu Y; Zhong X
Cancer Immunol Immunother; 2023 Jul; 72(7):2393-2403. PubMed ID: 36991262
[TBL] [Abstract] [Full Text] [Related]
10. Inclusion of 4-1BB Costimulation Enhances Selectivity and Functionality of IL13Rα2-Targeted Chimeric Antigen Receptor T cells.
Starr R; Aguilar B; Gumber D; Maker M; Huard S; Wang D; Chang WC; Brito A; Chiu V; Ostberg JR; Badie B; Forman SJ; Alizadeh D; Wang LD; Brown CE
Cancer Res Commun; 2023 Jan; 3(1):66-79. PubMed ID: 36968221
[TBL] [Abstract] [Full Text] [Related]
11. Artificial Intelligence and Advanced Melanoma: treatment Management Implications.
Guerrisi A; Falcone I; Valenti F; Rao M; Gallo E; Ungania S; Maccallini MT; Fanciulli M; Frascione P; Morrone A; Caterino M
Cells; 2022 Dec; 11(24):. PubMed ID: 36552729
[TBL] [Abstract] [Full Text] [Related]
12. Anticancer traits of chimeric antigen receptors (cars)-Natural Killer (NK) cells as novel approaches for melanoma treatment.
Bahmanyar M; Vakil MK; Al-Awsi GRL; Kouhpayeh SA; Mansoori Y; Mansoori B; Moravej A; Mazarzaei A; Ghasemian A
BMC Cancer; 2022 Nov; 22(1):1220. PubMed ID: 36434591
[TBL] [Abstract] [Full Text] [Related]
13. [The influence of lung metastasis on prognosis of previously untreated gestational trophoblastic neoplasia patients].
Lin JJ; Jiang F; Xiang Y; Wan XR; Feng FZ; Ren T; Yang JJ; Zhao J
Zhonghua Zhong Liu Za Zhi; 2022 Oct; 44(10):1139-1145. PubMed ID: 36319461
[No Abstract] [Full Text] [Related]
14. Diffuse Large B-cell Epstein-Barr Virus-Positive Primary CNS Lymphoma in Non-AIDS Patients: High Diagnostic Accuracy of DSC Perfusion Metrics.
Pons-Escoda A; García-Ruíz A; Naval-Baudin P; Grussu F; Viveros M; Vidal N; Bruna J; Plans G; Cos M; Perez-Lopez R; Majós C
AJNR Am J Neuroradiol; 2022 Nov; 43(11):1567-1574. PubMed ID: 36202547
[TBL] [Abstract] [Full Text] [Related]
15. Radiomic study on preoperative multi-modal magnetic resonance images identifies IDH-mutant TERT promoter-mutant gliomas.
Wang H; Zhang S; Xing X; Yue Q; Feng W; Chen S; Zhang J; Xie D; Chen N; Liu Y
Cancer Med; 2023 Feb; 12(3):2524-2537. PubMed ID: 36176070
[TBL] [Abstract] [Full Text] [Related]
16. Adjuvant Therapy of Nivolumab Combined With Ipilimumab Versus Nivolumab Alone in Patients With Resected Stage IIIB-D or Stage IV Melanoma (CheckMate 915).
Weber JS; Schadendorf D; Del Vecchio M; Larkin J; Atkinson V; Schenker M; Pigozzo J; Gogas H; Dalle S; Meyer N; Ascierto PA; Sandhu S; Eigentler T; Gutzmer R; Hassel JC; Robert C; Carlino MS; Di Giacomo AM; Butler MO; Muñoz-Couselo E; Brown MP; Rutkowski P; Haydon A; Grob JJ; Schachter J; Queirolo P; de la Cruz-Merino L; van der Westhuizen A; Menzies AM; Re S; Bas T; de Pril V; Braverman J; Tenney DJ; Tang H; Long GV
J Clin Oncol; 2023 Jan; 41(3):517-527. PubMed ID: 36162037
[TBL] [Abstract] [Full Text] [Related]
17. Special issue "The advance of solid tumor research in China": Prediction of Sunitinib efficacy using computed tomography in patients with pancreatic neuroendocrine tumors.
Chen L; Wang W; Jin K; Yuan B; Tan H; Sun J; Guo Y; Luo Y; Feng ST; Yu X; Chen MH; Chen J
Int J Cancer; 2023 Jan; 152(1):90-99. PubMed ID: 36111424
[TBL] [Abstract] [Full Text] [Related]
18. Association Between Food and Drug Administration Approval and Disparities in Immunotherapy Use Among Patients With Cancer in the US.
Ermer T; Canavan ME; Maduka RC; Li AX; Salazar MC; Kaminski MF; Pichert MD; Zhan PL; Mase V; Kluger H; Boffa DJ
JAMA Netw Open; 2022 Jun; 5(6):e2219535. PubMed ID: 35771575
[TBL] [Abstract] [Full Text] [Related]
19. Application of blood brain barrier models in pre-clinical assessment of glioblastoma-targeting CAR-T based immunotherapies.
Huang J; Li YB; Charlebois C; Nguyen T; Liu Z; Bloemberg D; Zafer A; Baumann E; Sodja C; Leclerc S; Fewell G; Liu Q; Prabhakarpandian B; McComb S; Stanimirovic DB; Jezierski A
Fluids Barriers CNS; 2022 Jun; 19(1):38. PubMed ID: 35650594
[TBL] [Abstract] [Full Text] [Related]
20. CAR-T Therapy for Pediatric High-Grade Gliomas: Peculiarities, Current Investigations and Future Strategies.
Antonucci L; Canciani G; Mastronuzzi A; Carai A; Del Baldo G; Del Bufalo F
Front Immunol; 2022; 13():867154. PubMed ID: 35603195
[TBL] [Abstract] [Full Text] [Related]
[Next]
